Search for: "Anda Pharmaceuticals, Inc"
Results 561 - 580
of 607
Sorted by Relevance
|
Sort by Date
5 Aug 2021, 12:12 pm
(collectively, GSK) sued Teva Pharmaceuticals USA, Inc. in the United States District Court for the District of Delaware for infringement of claims of GSK’s Reissue Patent No. [read post]
6 May 2010, 9:43 am
Teva Pharmaceuticals, USA, et al., 2009 WL 73274 (N.D.Ill. 03/16/09). [read post]
21 Oct 2009, 6:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) – US: Shire announces settlement… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
15 Feb 2011, 5:26 pm
: Ineos Healthcare v OHMI – Teva (Class 46) Androderm (Testosterone) – US: Watson settles with Promote Innovation in Androderm false marking suit (Patent Docs) Asacol (Mesalamine) – US: Roxane sanctioned in Asacol patent dispute with Medeva (Patent Docs) Detrol (Tolterodine) – US: Subsequent ANDA sponsor says Detrol LA patent has gotta go; But would a final court decision trigger 180-day exclusivity? [read post]
9 Feb 2009, 11:32 pm
(alleged infringers)Eli Lilly's (patent owner) Cymbalta drugAstraZeneca's (patent owner) Crestor drugPenwest Pharmaceuticals (patent owner) Opana ER drugSepracor's (patent owner) Xyzal drugOf Apple and US 7,479,949, see the IPBiz post Obvious? [read post]
9 Sep 2010, 7:09 pm
Zenith Goldline Pharmaceuticals, Inc., 471 F.3d 1369, 1377-79 (Fed. [read post]
29 Aug 2012, 3:15 am
Ranbaxy Pharmaceuticals, Inc., 336 F.3d 1322, 1330 (Fed. [read post]
6 Jul 2011, 2:21 am
Biopet Vet Lab, Inc., et. al. [read post]
11 May 2023, 1:16 pm
New Relists Teva Pharmaceuticals USA, Inc. v. [read post]
8 Aug 2022, 7:11 am
Hospira, Inc., 11 F.4th 1345 (Fed. [read post]
18 May 2016, 6:27 am
Apotex Inc. v. [read post]
3 Jul 2007, 10:47 am
Teleflex Inc., 127 S. [read post]
10 Sep 2012, 7:28 pm
., Glaxo, Inc. v. [read post]
21 Nov 2006, 9:58 am
Medtronic AVE, Inc., 339 F.3d 1352, 1363 (Fed. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
4 Sep 2010, 8:29 pm
Robotic Vision Sys., Inc. v. [read post]
